Drug Discovery Services
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT02718378
Evaluation of Safety and Efficacy of Estetrol in Healthy Men
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2016
Completion: Feb 28, 2017
NCT02718144
Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
Phase: Phase 1/2
Start: Jun 1, 2017
Completion: Dec 31, 2019
NCT03361969
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
Phase: Phase 2
Start: Apr 16, 2018
Completion: May 15, 2020
Loading map...